SCHEMBL659049

SCHEMBL659049

COCc1nc2cccc(I)c2s1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.39
RAB9A P51151 5/20 0.39
NPC1 O15118 5/20 0.39
MAPT P10636 5/20 0.39
PKM P14618 1/20 0.39
CYP1A2 P05177 1/20 0.37
CYP2C19 P33261 1/20 0.37
L3MBTL1 Q9Y468 4/20 0.36
MAPK1 P28482 1/20 0.36
KMT2A Q03164 2/20 0.33
HPGD P15428 1/20 0.33
HSD17B10 Q99714 1/20 0.33
POLB P06746 1/20 0.33
PTPN11 Q06124 1/20 0.32
HTT P42858 1/20 0.32
DRD2 P14416 1/20 0.32
DRD4 P21917 1/20 0.32
DRD3 P35462 1/20 0.32
ALDH1A1 P00352 1/20 0.31
PDE10A Q9Y233 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL660766 0.75 POLB (0.38) SMN1; SMN2RAB9ANPC1MAPTPKM
SCHEMBL660014 0.73 MAPT (0.67) SMN1; SMN2RAB9ANPC1MAPTPKM
SCHEMBL658951 0.72 NPC1 (0.33) SMN1; SMN2RAB9ANPC1MAPTPKM
SCHEMBL1528140 0.71 SMN1; SMN2 (0.43) SMN1; SMN2RAB9ANPC1MAPTPKM
SCHEMBL28806354 0.70 PSMB8 (0.33) SMN1; SMN2RAB9ANPC1MAPTL3MBTL1
SCHEMBL23208971 0.69 PTPN11 (0.39) SMN1; SMN2RAB9ANPC1MAPTPKM
SCHEMBL8052343 0.67 NPC1 (0.48) SMN1; SMN2RAB9ANPC1MAPTPKM
SCHEMBL1527927 0.66 TLR8 (0.72) POLB
SCHEMBL23405330 0.62 MAPT (0.43) SMN1; SMN2RAB9ANPC1MAPTPKM
SCHEMBL21673258 0.62 SMN1; SMN2 (0.43) SMN1; SMN2RAB9ANPC1MAPTPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8378104-B2 7-aminofuropyridine derivatives OSI Pharmaceuticals, LLC (US) 2013-02-19 US disclosed
EP-2534156-A1 7-AMINOFUROPYRIDINE DERIVATIVES OSI Pharmaceuticals, LLC (US) 2012-12-19 EP disclosed
US-20120046267-A1 7-AMINOFUROPYRIDINE DERIVATIVES OSI PHARMACEUTICALS, INC. 2012-02-23 US disclosed
WO-2011100502-A1 7-AMINOFUROPYRIDINE DERIVATIVES OSI Pharmaceuticals, LLC (US) 2011-08-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046267-A1 7-AMINOFUROPYRIDINE DERIVATIVES MAP3K5, STK17A, MAPKAPK5 SMN1; SMN2 1807/4885RAB9A 1727/4885NPC1 976/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.